Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd's latest stock split occurred on May 29, 2018
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, Mizuho Medy Co Ltd traded at 5860 per share. Afterward, the share price was about 2692.351.
The adjusted shares began trading on May 29, 2018. This was Mizuho Medy Co Ltd's 2nd stock split, following the previous one in Jun 28, 2017.
YLLWF
CMB
RNT
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
You don't have any saved screeners yet